Prostatype Genomics presents Interim Report for the period 1 April to 30 June 2021
- Prostatype Genomics presents Quarterly report for the second quarter of 2021. The Report is available on the Company's home page.Quarter 2 (1 April – 30 June 2021) summarized · Net sales amounted to 549 TSEK. · Net revenue amounted to 5 TSEK. · EBITDA (earnings before interest, taxes, depreciation, and amortization) amounted to -2 373 TSEK. · Cash flow from current operations in the quarter amounted -2 353 TSEK. · Total cash flow for the period amounted to -2 862 TSEK. · Earnings per share amounted to -0,18 SEK. Significant events during the Second Quarter ·